See-Mode: Using AI to Predict Recurrent Stroke Risk


After clinicians successfully deal with an acute ischemic stroke, they still face the ongoing challenge of managing a patient facing a high risk of stroke recurrence. See-Mode Technologies is developing AI-enabled software that can detect, on routine ultrasound, CT and MR images, risk factors normally only detectable by advanced imaging modalities.

The care of ischemic stroke has advanced rapidly in the past five years since endovascular clot removing techniques have proven themselves able to save the lives—and the quality of life—of many patients. (See “Ischemic Stroke: The First Pass Effect,” MedTech Strategist, September 13, 2019.)

This article is restricted to subscribers only.

To continue reading, select one of the options below:

Existing Subscriber?

Sign In to continue reading.

Need Multi-User Access?

Gain access for your entire organization.

Get Quote Check to see if your company already has access

Subscribe to MedTech Strategist:

Actionable intelligence exploring the people, challenges, and opportunities impacting the global medtech community.

Subscribe to MedTech Strategist
Subscribe to ELITE Strategist

Become an ELITE Strategist and unlock access to both MedTech Strategist and MTS Market Pathways.

Subscribe to Elite


We're here to help! Please contact us at: